Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $16.2200 (2.46%) ($15.8600 - $16.4800) on Tue. Aug. 13, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 44 | Latest Price | $16.2200(2.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.1% a day on average for past five trading days. | Weekly Trend | HALO declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(54%) IWO(54%) IWM(49%) XBI(49%) IWC(48%) | Factors Impacting HALO price | HALO will decline at least -0.815% in a week (0% probabilities). VIXM(-37%) VXX(-20%) UUP(-6%) TLT(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
1 - 5 Day Possible Target | $12.02(-25.89%) | Resistance Level | $16.64 | 5 Day Moving Average | $16.19(0.19%) | 10 Day Moving Average | $16.59(-2.23%) | 20 Day Moving Average | $16.64(-2.52%) | To recent high | -8.3% | To recent low | 10% | Market Cap | $2.217b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |